First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
The quarterly LOR summary is produced by
Each quarter, I round up and highlight some of my favorite articles written by Mitchell experts and let you know where we have been published outsi
From business rules engines to artificial intelligence, both existing and new technologies yield opportunities for better, more strateg
"You only get one chance to make a first impression.” This common phrase is especially true in establishing a positive relationship between an inju
While new vehicle sales numbers have cooled from the records of the previous couple of years, the strength of the US economy continues to have an i
July 2019 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Executive Vice-President, ADESA Analytical Se